Medical Weight Loss for Des Plaines, Illinois Residents

Des Plaines, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Des Plaines through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Illinois: there is no local Des Plaines office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Des Plaines Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Des Plaines a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Illinois. That is the entire promise, and we keep it.

Medical weight loss for Des Plaines is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

For anyone in Des Plaines, Illinois, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout downtown Des Plaines and the northwest Chicago suburbs near O'Hare. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Illinois.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Des Plaines or a rural corner of Illinois. Between Klarna, Affirm, and HSA or FSA cards, Des Plaines patients have several ways to handle the $119 review and ongoing medication payments. From the big cities to the small towns of Illinois, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Des Plaines patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Des Plaines

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Des Plaines. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Des Plaines address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Des Plaines

Does New Hope Weight Loss have a presence in Des Plaines?

Our presence in Des Plaines is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Des Plaines, Illinois patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Des Plaines patient complete care without leaving home?

Yes, staying home is the norm. Everything for Des Plaines patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Des Plaines in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Des Plaines patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Des Plaines.

What areas of Des Plaines do you serve?

We serve patients from across Des Plaines by telehealth, including downtown Des Plaines and the northwest Chicago suburbs near O'Hare.

Is my health information private as a Des Plaines patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Des Plaines patients get the same confidentiality as any telehealth patient.

Des Plaines Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Des Plaines, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.